ANDA 208209, held by Accord Hlthcare. Vilazodone Hydrochloride.
As of Nov 16, 2026, ANDA 208209 (Vilazodone Hydrochloride), held by Accord Hlthcare, was first approved by FDA on Apr 27, 2021, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 27, 2021 | Original application | Approved | None posted |
| Vilazodone Hydrochloride10MG · tablet;oral | Vilazodone Hydrochloride | Rx |
| Vilazodone Hydrochloride20MG · tablet;oral | Vilazodone Hydrochloride | Rx |
| Vilazodone Hydrochloride40MG · tablet;oral | Vilazodone Hydrochloride | Rx |
| Jan 3, 2025 | Supplement 4Labeling · Standard review | Approved | None posted |
| Jan 11, 2024 | Supplement 2Labeling · Standard review | Approved | None posted |
| Jun 7, 2023 | Supplement 1Labeling · Standard review | Approved | None posted |
| Apr 27, 2021 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters